Clinical Trial Update: ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension [EARLY_Phase 1]

View source ↗

Summary

ASPIRED-XT is an extension of an early-phase trial testing aspirin to reduce colorectal cancer risk; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Colorectal Cancer | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING